Clinical Study Confirms Effectiveness of CardioSecur® in Pre-Clinical Deployment in Ambulances

CardioSecurThe study "CardioSecur® in the preclinical setting - When time does matter" of the University of Heidelberg confirms the advantages of the mobile ECG in acute cases. This was demonstrated by applying CardioSecur during a period of more than 7 months in ambulances in the area of Heidelberg, Germany.

85.7 % of participating emergency physicians stated that CardioSecur's 4 electrode system was much faster and easier to position in emergency situations and would prefer using it over a conventional 12-lead ECG. Additionally, CardioSecur's 22-leads provide more data (12 leads + V7-9, VR3-VR9) than a standard ECG. The 360° view of the heart enables more comprehensive diagnoses, for example of a posterior myocardial infarction, and can be vital in acute situations. Consequently, the study confirms the efficiency of CardioSecur in time-critical preclinical settings. The system also significantly reduces the risk of electrode misplacement in obese patients and women.

Time plays a crucial role in patients with suspected acute coronary syndrome, as the heart muscle begins to die off only 20 - 60 minutes after the coronary vessel’s blood supply has ceased. During the so-called "golden hour" immediate action is essential to minimize heart muscle damage and optimize patient recovery. Conventional 12 lead ECG systems require 10 electrodes and their placement affects the quality of the ECG significantly. Placement of the 6 chest leads can be particularly complex and time-consuming due to very different body anatomies. CardioSecur’s 4 electrode based 22-lead ECG is faster and easier to position, while also providing more data to detect posterior, lateral and anterior myocardial infarctions.

"Currently, 12-lead ECG systems provide insufficient data to detect posterior myocardial infarctions because in practice the electrodes are rarely placed on the patient's back - even though the ESC guidelines require it," says Felix Brand, founder and CEO of CardioSecur. "The repositioning of the dorsal electrodes also results in an asynchronous ECG (anterior and posterior). CardioSecur is currently the only ECG that meets the cardiological guidelines of the ESC without need for repositioning the electrodes. CardioSecur has already helped to detect posterior myocardial infarctions that were not visible on conventional 12-lead ECGs."

For further information, please visit:
http://www.mobile-ecg.com

About Personal MedSystems GmbH

Personal MedSystems GmbH develops and sells ECG systems and services for private users and healthcare professionals under the name CardioSecur. CardioSecur Active is an innovative, 15-lead, clinical-grade ECG for personal use. In a few seconds, it generates personalized feedback regarding changes in the heart's health and provides a simple recommendation to act regarding whether to see a doctor or not. The entire system consists of a 50g light cable with four electrodes, the complimentary CardioSecur Active App and the user's smartphone or tablet. CardioSecur Pro is the mobile, clinical ECG solution for physicians and medical professionals. CardioSecur Pro operates based upon guidelines from the European Society of Cardiology by providing 22 leads, making a 360° view of the heart possible. It is the only system that thereby recognizes infarctions of the anterior, lateral and posterior walls of the heart.

Most Popular Now

Artificial Intelligence Detects a New Cl…

Many mutations in DNA that contribute to disease are not in actual genes but instead lie in the 99% of the genome once considered "junk." Even though scientists have recently...

Essen University Medicine and Siemens He…

The Essen University Medicine, Germany's leading hospital company for digitalized medicine, and Siemens Healthineers, a world-leading medical technology company, plan to work together to develop the hospital of the future...

Final Cohort Selected For Pioneering Dig…

Propel@YH has announced the six start-ups to participate in its inaugural digital health accelerator programme, aimed at navigating the complex healthcare landscape and building an NHS-relevant business case. The Leeds-based...

New Kid on the Block: The Doctrina Acade…

The Doctrina Academy is a new service, developed by Doctrina, a video e-learning platform that reaches over 1,000,000 healthcare professionals (HCPs) from around the globe, helping them to switch ...

Efficacy and SilverCloud Health Supports…

A leading mental health service is using the digital mental health platform developed by SilverCloud Health to support a confidential NHS service for GPs in England. London-based Efficacy is offering...

Gloucestershire Hospitals to Deliver EPR…

Gloucestershire Hospitals NHS Foundation Trust is moving to a 'clinical wrap' strategy to deliver an electronic patient record (EPR) and achieve the highest levels of digital maturity within five-years. The...

Mobile Phone App Designed to Boost Physi…

Activity trackers and mobile phone apps are all the rage, but do they really help users increase and maintain physical activity? A new study has found that one mobile phone...

Application Period for an International …

The Master of Science (M.Sc.)in Medical Informatics (MMI) at European Campus Rottal-Inn (ECRI) in Pfarrkirchen - a branch of the Deggendorf University of Applied Sciences (THD - Technische Hochschule Deggendorf)...

NHS Prescribing is Back in the Spotlight…

Opinion Article by Dr Simon Hendricks, Product Innovation Manager and Clinical Strategy Lead, FDB (First Databank) Political will for better and safer prescribing in the NHS has fast gained momentum in...

Sectra to Provide Large Centralized Regi…

International medical imaging IT and cybersecurity company Sectra (STO: SECT B) has signed a five-year contract with North Tees and Hartlepool NHS Foundation Trust for the delivery of a regional...

IMI to Boost Patient Involvement in its …

The Innovative Medicines Initiative (IMI) is creating a 'pool' of patient experts to strengthen the role and voice of patients in IMI activities at both strategic and operational levels. IMI...